Search

everythinglearnresearchcommunity

for

Search:↓

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

miR-200c-3p could help diagnose and treat alopecia areata.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

miR-155 levels in blood could help identify alopecia areata.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Ruxolitinib helped a patient with alopecia areata regrow hair.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

Autoimmune skin diseases result from genetic and environmental factors disrupting immune checkpoints.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

RDW can be a useful marker for inflammation in alopecia areata patients.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Targeting specific T cells may help treat alopecia areata.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

More precise, personalized therapies are needed for autoimmune diseases.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Alopecia Areata often runs in families and is linked to other autoimmune conditions.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Patients with alopecia areata should be checked for muscle spasms, diarrhea, and ANA to avoid missing Satoyoshi syndrome.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.